|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
53,543,000 |
Market
Cap: |
11.06(B) |
Last
Volume: |
666,758 |
Avg
Vol: |
474,971 |
52
Week Range: |
$164.52 - $273.43 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 456 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Charles River Laboratories International is a contract research organization. Co. has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. Co.'s segments include: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; Manufacturing Support, which ensure the safe production and release of products manufactured by Co.'s clients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,942 |
11,192 |
Total Buy Value |
$0 |
$0 |
$1,447,725 |
$2,162,353 |
Total People Bought |
0 |
0 |
3 |
3 |
Total Buy Transactions |
0 |
0 |
3 |
5 |
Total Shares Sold |
1,636 |
25,558 |
49,996 |
92,833 |
Total Sell Value |
$374,194 |
$6,377,856 |
$11,292,577 |
$21,658,880 |
Total People Sold |
2 |
6 |
6 |
8 |
Total Sell Transactions |
2 |
10 |
16 |
28 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
AS |
$140.44 |
$556,159 |
D/D |
(3,957) |
293,361 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
AS |
$139.88 |
$485,077 |
D/D |
(3,459) |
297,318 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
OE |
$76.67 |
$1,654,309 |
D/D |
21,577 |
300,777 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
AS |
$141.89 |
$470,516 |
D/D |
(3,312) |
279,713 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-02-27 |
4 |
S |
$140.82 |
$1,150,072 |
D/D |
(8,155) |
23,701 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
AS |
$142.45 |
$73,095 |
D/D |
(513) |
279,200 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
AS |
$141.59 |
$462,513 |
D/D |
(3,263) |
283,025 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-02-27 |
4 |
S |
$140.58 |
$1,578,852 |
D/D |
(11,222) |
31,856 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
AS |
$141.12 |
$381,614 |
D/D |
(2,699) |
286,288 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2019-02-27 |
4 |
D |
$140.71 |
$17,589 |
D/D |
(125) |
24,045 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2019-02-27 |
4 |
D |
$140.71 |
$21,951 |
D/D |
(156) |
14,783 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-02-27 |
4 |
D |
$140.57 |
$30,644 |
D/D |
(218) |
18,415 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-02-27 |
4 |
D |
$140.71 |
$30,675 |
D/D |
(218) |
28,201 |
|
- |
|
Johst David P |
Corporate Executive VP |
|
2019-02-27 |
4 |
D |
$140.71 |
$87,381 |
D/D |
(621) |
212,854 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-27 |
4 |
D |
$140.71 |
$305,481 |
D/D |
(2,171) |
279,200 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-02-27 |
4 |
AS |
$140.04 |
$304,435 |
D/D |
(2,158) |
18,415 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-02-27 |
4 |
OE |
$76.67 |
$165,454 |
D/D |
2,158 |
20,573 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-02-27 |
4 |
S |
$140.27 |
$747,921 |
D/D |
(5,324) |
43,078 |
|
- |
|
Barbo William D |
Corporate Executive VP & CCO |
|
2019-02-27 |
4 |
OE |
$59.41 |
$1,683,555 |
D/D |
20,201 |
48,402 |
|
- |
|
Girshick Birgit |
Corporate Executive VP |
|
2019-02-26 |
4 |
D |
$145.31 |
$22,087 |
D/D |
(152) |
24,170 |
|
- |
|
Laplume Joseph W |
EVP, Corp Strategy & Develop |
|
2019-02-26 |
4 |
D |
$145.31 |
$44,174 |
D/D |
(304) |
14,939 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-02-26 |
4 |
AS |
$139.32 |
$566,015 |
D/D |
(4,050) |
20,220 |
|
- |
|
Smith David Ross |
Corporate Executive VP & CFO |
|
2019-02-26 |
4 |
OE |
$73.70 |
$308,582 |
D/D |
4,187 |
24,270 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-26 |
4 |
AS |
$140.11 |
$515,131 |
D/D |
(3,673) |
290,115 |
|
- |
|
Foster James C |
Chairman, President and CEO |
|
2019-02-26 |
4 |
AS |
$139.64 |
$708,659 |
D/D |
(5,072) |
297,287 |
|
- |
|
1200 Records found
|
|
Page 24 of 48 |
|
|